Glen Eagle Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 19,523 shares of XBI stock, worth $1.91 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

19,523

Previous 14,668 33.1%

Holding current value

$1.91 Million

Previous $1.29 Billion 40.66%

% of portfolio

0.33%

Previous 1.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$82.22 - $94.12 $399,178 - $456,952	4,855 Added 33.1%	19,523 $1.81 Billion
Q1 2024 Jul 03, 2024	BUY	$87.05 - $102.89 $1.69 Million - $2 Million	19,403 New	19,403 $1.84 Billion
Q4 2023 Aug 13, 2024	BUY	$64.12 - $90.86 $43,601 - $61,784	680 Added 3.7%	19,063 $1.7 Billion
Q3 2023 Aug 13, 2024	BUY	$71.88 - $85.76 $8,481 - $10,119	118 Added 0.65%	18,383 $1.34 Billion
Q2 2023 Aug 13, 2024	BUY	$75.38 - $90.23 $182,193 - $218,085	2,417 Added 15.25%	18,265 $1.52 Billion
Q1 2023 Aug 13, 2024	SELL	$73.13 - $91.97 $17,770 - $22,348	-243 Reduced 1.51%	15,848 $1.21 Billion
Q4 2022 Aug 13, 2024	SELL	$77.2 - $85.66 $98,430 - $109,216	-1,275 Reduced 7.34%	16,091 $1.34 Billion
Q3 2022 Aug 13, 2024	SELL	N/A	-344 Reduced 1.94%	17,366 $1.38 Billion
Q2 2022 Aug 13, 2024	SELL	N/A	-1,115 Reduced 5.92%	17,710 $1.32 Billion
Q1 2022 Aug 13, 2024	BUY	N/A	55 Added 0.29%	18,825 $1.69 Billion
Q4 2021 Aug 13, 2024	BUY	N/A	226 Added 1.22%	18,770 $2.1 Billion
Q3 2021 Aug 13, 2024	BUY	N/A	433 Added 2.39%	18,544 $2.33 Billion
Q2 2021 Aug 13, 2024	BUY	N/A	395 Added 2.23%	18,111 $2.45 Billion
Q1 2021 Aug 13, 2024	BUY	N/A	495 Added 2.87%	17,716 $2.4 Billion
Q4 2020 Aug 13, 2024	SELL	N/A	-2,182 Reduced 11.25%	17,221 $2.42 Billion
Q3 2020 Aug 13, 2024	BUY	N/A	180 Added 1.06%	17,176 $1.91 Billion
Q2 2020 Aug 13, 2024	BUY	N/A	320 Added 1.92%	16,996 $1.9 Billion
Q1 2020 Aug 13, 2024	SELL	N/A	-145 Reduced 0.86%	16,676 $1.29 Billion
Q4 2019 Aug 13, 2024	BUY	N/A	1,862 Added 12.45%	16,821 $1.6 Billion
Q3 2019 Aug 13, 2024	SELL	N/A	-921 Reduced 5.8%	14,959 $1.14 Billion
Q2 2019 Aug 13, 2024	BUY	N/A	252 Added 1.61%	15,880 $1.39 Billion
Q1 2019 Aug 13, 2024	SELL	N/A	-3,775 Reduced 19.46%	15,628 $1.41 Billion
Q4 2018 Aug 13, 2024	SELL	N/A	-1,385 Reduced 8.08%	15,753 $1.1 Billion
Q3 2018 Aug 13, 2024	BUY	N/A	1,595 Added 10.26%	17,138 $1.64 Billion
Q2 2018 Aug 13, 2024	SELL	N/A	-1,146,823 Reduced 98.66%	15,543 $1.48 Billion
Q1 2018 Aug 14, 2024	SELL	N/A	-4,735 Reduced 24.4%	14,668 $1.29 Billion
Q1 2018 Aug 13, 2024	BUY	N/A	1,149,729 Added 9098.12%	1,162,366 $1.29 Billion
Q4 2017 Aug 13, 2024	BUY	N/A	2,161 Added 20.63%	12,637 $1.07 Billion
Q3 2017 Aug 13, 2024	SELL	N/A	-8,927 Reduced 46.01%	10,476 $907 Million
Q2 2017 Aug 12, 2024	BUY	N/A	670 Added 4.09%	17,060 $1.33 Billion
Q1 2017 Aug 12, 2024	BUY	N/A	770 Added 4.93%	16,390 $1.14 Billion
Q4 2016 Aug 12, 2024	SELL	N/A	-3,783	15,620 $925 Million

Others Institutions Holding XBI

# of Institutions

894

Shares Held

94.6M

Call Options Held

18.4M

Put Options Held

31.6M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History